Aldevron LLC:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Aldevron LLC - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C0475
◆発行会社(調査会社):GlobalData
◆発行日:2018年7月
◆ページ数:26
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Aldevron LLC (Aldevron) is a provider of contract plasmid DNA manufacturing, protein production and antibody discovery services. The company develops and manufactures plasmid deoxyribonucleic acid (Plasmid DNA), proteins and antibodies for research, preclinical and clinical applications serving biotechnology industry. Its antibody development services include protein immunization, antibody sequencing and discovery, peptide and genetic immunization. The company also offers support services in RNA production, gene synthesis; aldevron storage, distribution and stability (ASDS) service and others. The company has operations with manufacturing facilities in Fargo, Madison, the US; and Freiburg, Germany. Aldevron is headquartered in Fargo, North Dakota, the US.

Aldevron LLC – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Aldevron LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Aldevron LLC, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Aldevron LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Aldevron LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Aldevron LLC, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Aldevron LLC, Pharmaceuticals & Healthcare, Deal Details 10
Private Equity 10
TA Associates Invests in Aldevron 10
Partnerships 11
Aldevron to Partner with Myeloma Crowd Research Initiative 11
DNA2.0 And Aldevron Enter Into Agreement For Insect Cell Expression System 12
Licensing Agreements 13
Aldevron Enters into Licensing Agreement with Integrated DNA Technologies 13
Aldevron Enters into Licensing Agreement with Stanford University 14
Aldevron LLC – Key Competitors 15
Aldevron LLC – Key Employees 16
Aldevron LLC – Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Recent Developments 18
Corporate Communications 18
May 30, 2018: Aldevron hires Don Kania to board of directors 18
May 15, 2018: Aldevron Names Marc Wolff Chief Financial Officer 19
Aug 17, 2017: Five new employees joined in Aldevron 20
May 23, 2017: Aldevron Names Biomanufacturing Veteran Henry Hebel as New Chief Operating Officer 21
Government and Public Interest 22
Apr 16, 2018: Aldevron to host inaugural Breakthrough Symposium 22
Product News 23
Nov 15, 2017: Aldevron Announces Availability of GMP SpCas9 23
Feb 21, 2018: Aldevron Announces Ready-to-Use AAV Helper Plasmid 24
Other Significant Developments 25
Feb 14, 2017: Aldevron expands manufacturing scale and implements single-use fermentation technology 25
Appendix 26
Methodology 26
About GlobalData 26
Contact Us 26
Disclaimer 26

List of Tables
Aldevron LLC, Pharmaceuticals & Healthcare, Key Facts 2
Aldevron LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Aldevron LLC, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Aldevron LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Aldevron LLC, Deals By Therapy Area, 2012 to YTD 2018 8
Aldevron LLC, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
TA Associates Invests in Aldevron 10
Aldevron to Partner with Myeloma Crowd Research Initiative 11
DNA2.0 And Aldevron Enter Into Agreement For Insect Cell Expression System 12
Aldevron Enters into Licensing Agreement with Integrated DNA Technologies 13
Aldevron Enters into Licensing Agreement with Stanford University 14
Aldevron LLC, Key Competitors 15
Aldevron LLC, Key Employees 16
Aldevron LLC, Other Locations 17
Aldevron LLC, Subsidiaries 17

List of Figures
Aldevron LLC, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Aldevron LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Aldevron LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Aldevron LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Aldevron LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Aldevron LLC, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Aldevron LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Aldevron LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Aldevron LLC:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • AusNet Services Ltd (AST):電力:M&Aディール及び事業提携情報
    Summary AusNet Services Ltd. (AusNet) is a diversified energy network business entity that transmits and distributes power and distributes gas. It owns and manages electricity transmission network in Victoria; and delivers electricity to various customer connection points in eastern Victoria includi …
  • Redbiotec AG:製薬・医療:M&Aディール及び事業提携情報
    Summary Redbiotec AG (Redbiotec) is a biopharmaceutical company that develops prophylactic vaccines, which target various virus associated diseases. The company produces multi component virus like particles and other protein assemblies through its rePAX coexpression technology. It is developing prod …
  • TransAlta Corp:企業の発電所・SWOT分析2018
    TransAlta Corp - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (exe …
  • Groupe Lactalis S.A.:企業のM&A・事業提携・投資動向
    Groupe Lactalis S.A. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Groupe Lactalis S.A. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A …
  • Maritz Holdings Inc.:企業の戦略的SWOT分析
    Maritz Holdings Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Viscofan, S.A.:企業の戦略・SWOT・財務情報
    Viscofan, S.A. - Strategy, SWOT and Corporate Finance Report Summary Viscofan, S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Opthea Ltd (OPT)-医療機器分野:企業M&A・提携分析
    Summary Opthea Ltd (Opthea), formerly Circadian Technologies Ltd is a provider of research and development of angiogenesis and vascular leakage-based treatments for cancer focusing on vascular endothelial growth factors. The company’s pipeline products comprise VEGF-C, VEGF-D and VEGFR-3. Opthea’s d …
  • Southern Minnesota Municipal Power Agency:発電所・企業SWOT分析
    Southern Minnesota Municipal Power Agency - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, inform …
  • ThreeD Capital:企業のM&A・事業提携・投資動向
    ThreeD Capital - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's ThreeD Capital Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestmen …
  • Maruho Co Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Maruho Co Ltd (Maruho) is a pharmaceutical company that carries out the research, development, production, and distribution of dermatological products. It product portfolio includes a wide range of prescription drugs, medical devices and other skincare products. The company also offers produ …
  • Finnair Oyj:企業のM&A・事業提携・投資動向
    Finnair Oyj - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Finnair Oyj Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, ca …
  • Actavalon Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Actavalon Inc (Actavalon) is an oncology-focused company, which develops small molecule medicines targeting two basic cancer pathways, namely, the p53 tumor suppressor pathway and the aryl hydrocarbon receptor (AhR) pathway. It is developing small molecules that can stabilize the mutant p53 …
  • Selective Insurance Group, Inc. (SIGI):企業の財務・戦略的SWOT分析
    Selective Insurance Group, Inc. (SIGI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …
  • Fresenius SE & Co KGaA (FRE)-医療機器分野:企業M&A・提携分析
    Summary Fresenius SE & Co KGaA (Fresenius) is a global health care group, which offers products and services for dialysis treatment. It provides various dialysis services through its own clinics and sells its products to other dialysis service providers. Its major products and services includes mach …
  • Valvoline Inc (VVV):企業の財務・戦略的SWOT分析
    Valvoline Inc (VVV) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Jamaica Public Service Co Ltd:企業の戦略的SWOT分析
    Jamaica Public Service Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …
  • ERG Renew SpA:企業の戦略的SWOT分析
    ERG Renew SpA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • Vexim SA (ALVXM):企業の財務・戦略的SWOT分析
    Summary Vexim SA (Vexim), a subsidiary of Stryker Corp, is a healthcare product manufacturer that provides solutions for patients suffering from vertebral compression fractures. The company provides solutions such as controlled anatomical restoration and advanced vertebroplasty therapy. Its controll …
  • Mitsubishi Heavy Industries Ltd (7011):企業の財務・戦略的SWOT分析
    Mitsubishi Heavy Industries Ltd (7011) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …
  • Tarsa Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Tarsa Therapeutics Inc (Tarsa) is a developer of therapies for the treatment and prevention of osteoporosis and other bone related diseases. The company develops calcitonin tablet TBRIA, an oral formulation of calcitonin, a peptide hormone that inhibits bone resorption, which is used for the …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆